News

A bipartisan group of lawmakers introduced legislation this week to extend CMS’ hospital-at-home waiver for five more years, allowing hospitals to continue delivering acute care in patients’ homes with Medicare reimbursement. The move comes as research shows this model reduces mortality and healthcare costs. The post New Legislation Seeks to Preserve Hospital-at-Home Reimbursement Until 2030 […]

Capricor Therapeutics said the FDA asked for more data supporting the efficacy of Deramiocel, the biotech’s off-the-shelf cell therapy for treating the heart complications of Duchenne muscular dystrophy. Those data could come from an ongoing Phase 3 study expected to yield preliminary results soon. The post FDA Turns Down Capricor Cell Therapy for Cardio Complications […]

We can’t ignore what AI makes possible: faster diagnoses, smarter workflows, better use of limited resources, and more personalized care at scale. If we get this right, we can build a system that works better for everyone, not just the few who can afford concierge care or live near major medical centers. The post AI […]

As AI tools continue to evolve, they promise to empower clinicians and administrators with actionable insights, improve patient outcomes, and create more resilient healthcare systems. The post Upholding “Do No Harm” in the Age of AI appeared first on MedCity News.

The right technology infrastructure enables organizations to link their teams and achieve better care outcomes while improving operational efficiency and developing lasting resilience. The post Closing the Gap Between Patient Care and Operations with Smarter, Scalable Tech appeared first on MedCity News.

[Sponsored] In this whitepaper, ProviderTrust outlines the overwhelmingly positive survey results and compares them to our experiences getting up close and personal with the provider data in question. The post Is Payers’ Provider Data “Clean, Complete, and Centralized” or is There a Crisis of Overconfidence? appeared first on MedCity News.

Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year. The post Hospital M&A […]

AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile. The post AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma appeared first […]

[Sponsored] Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice. The post 6 Aesthetic Certification Programs That Include Both Theory and Practical Training appeared first on MedCity News.

Too many men ignore symptoms until they can no longer function. We end up seeing them in the emergency room, sometimes with late-stage cancer or uncontrolled chronic disease that could have been managed if addressed earlier. The post Rethinking Masculinity in Men’s Health appeared first on MedCity News.

Virtual visits have demonstrated solid potential to expand access, reduce in‑office congestion, and support continuity of care, but implementing these tools successfully relies on careful planning and strategy.  The post Five Key Considerations for Integrating Virtual Care into Your Practice appeared first on MedCity News.

AI is no panacea, but it can have a role in turning artisanal, trial-and-error drug development into a rapid, cost-effective, data-driven process. The post AI Meets Gene Editing: the Path to Plug-and-Play Drug Development appeared first on MedCity News.

We’re getting close to the July 19 deadline for submissions. Don’t miss this opportunity to pitch your company to a team of investors at INVEST Digital Health in Dallas on September 18! The post Is Your AI-Driven Healthcare Startup Ready for New Investment? Apply to INVEST Digital Health Pitch Perfect Today. appeared first on MedCity […]

[Sponsored] CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients’ blood pressure, operating in a similar way to continuous glucose monitors. Watch or […]

Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product in COPD alone, its potential extends to other respiratory disorders as well. The post Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to […]

For hospitals and health systems, the challenge is steep, but so is the opportunity. TEAM offers a framework to deliver more coordinated, cost-effective, and patient-focused care. Those who prepare now will be far better positioned to thrive in a value-based future. The post Mandatory by 2026: 5 Ways to Prepare for CMS’ TEAM Payment Model […]

GLP-1s are a breakthrough, but they are not the end of the story. To ensure lasting success, we must pair pharmacological interventions with behavioral support, personalized data, and continuous guidance. The post Beyond the Prescription: Supporting Long-Term Metabolic Health After GLP-1s appeared first on MedCity News.

[Sponsored] At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch. The post The Human Algorithm: What AI Can’t Replace in Pharma Engagement appeared first on MedCity News.

Samsung announced plans to acquire Xealth, a startup that helps hospitals integrate digital tools into clinical workflows, as part of its broader push into U.S. healthcare. The deal reflects growing provider demand for tech solutions and comes amid newfound optimism in the digital health exit market. The post Samsung Deepens Healthcare Bet With Xealth Acquisition […]

Novartis malaria drug Coartem has expanded its approval to include babies. The combination drug, originally formulated as a tablet, has a new dose strength and formulation designed for treating newborns and young infants who develop malarial infections. The post Novartis Drug Becomes First Malaria Therapy for Newborns and Infants appeared first on MedCity News.